Vascular Biogenics Receives New Coverage from Analysts at StockNews.com
| VBLTDelisted Stock | USD 0.28 0.01 3.45% |
Slightly above 61% of Vascular Biogenics' investor base is looking to short. The analysis of current outlook of investing in Vascular Biogenics suggests that many traders are alarmed regarding Vascular Biogenics' prospects. Vascular Biogenics' investing sentiment can be driven by a variety of factors including economic data, Vascular Biogenics' earnings reports, geopolitical events, and overall market trends.
Vascular |
StockNews.com started coverage on shares of Vascular Biogenics in a report issued on Saturday. The firm issued a sell rating on the biopharmaceutical companys stock. Vascular Biogenics Stock Performance Shares of NASDAQVBLT opened at 0.22 on Friday. The firm has a market cap of 16.69 million, a price-to-earnings ratio of -1.02
Read at thelincolnianonline.com
 |
Vascular Biogenics Fundamental Analysis
We analyze Vascular Biogenics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vascular Biogenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vascular Biogenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Vascular Biogenics is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Vascular Biogenics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vascular Biogenics stock to make a market-neutral strategy. Peer analysis of Vascular Biogenics could also be used in its relative valuation, which is a method of valuing Vascular Biogenics by comparing valuation metrics with similar companies.
Peers
Vascular Biogenics Related Equities
| ZVSA | ZyVersa Therapeutics | 13.76 | ||||
| VRAX | Virax Biolabs | 9.95 | ||||
| ZURA | Zura Bio | 9.79 | ||||
| INZY | Inozyme Pharma | 7.72 | ||||
| ATXI | Avenue Therapeutics | 6.74 | ||||
| PHIO | Phio Pharmaceuticals | 3.68 | ||||
| RNAZ | Transcode Therapeutics | 3.12 | ||||
| ABOS | Acumen Pharmaceuticals | 2.70 | ||||
| TERN | Terns Pharmaceuticals | 1.41 | ||||
| DAWN | Day One | 0.94 | ||||
| XFOR | X4 Pharmaceuticals | 1.33 | ||||
| REVB | Revelation Biosciences | 1.52 | ||||
| ALLR | Allarity Therapeutics | 4.50 | ||||
| HOOK | Hookipa Pharma | 4.62 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |